nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibuprofen—ABCC1—Mitoxantrone—lymphatic system cancer	0.122	0.179	CbGbCtD
Ibuprofen—ABCC1—Vincristine—lymphatic system cancer	0.0839	0.123	CbGbCtD
Ibuprofen—SLC22A11—Methotrexate—lymphatic system cancer	0.0679	0.0997	CbGbCtD
Ibuprofen—ABCC4—Methotrexate—lymphatic system cancer	0.0632	0.0928	CbGbCtD
Ibuprofen—CYP2C19—Teniposide—lymphatic system cancer	0.0522	0.0766	CbGbCtD
Ibuprofen—ABCC1—Methotrexate—lymphatic system cancer	0.0508	0.0746	CbGbCtD
Ibuprofen—SLCO1A2—Methotrexate—lymphatic system cancer	0.0454	0.0666	CbGbCtD
Ibuprofen—CYP2C9—Teniposide—lymphatic system cancer	0.0434	0.0637	CbGbCtD
Ibuprofen—SLC22A8—Methotrexate—lymphatic system cancer	0.0395	0.058	CbGbCtD
Ibuprofen—ABCB1—Mitoxantrone—lymphatic system cancer	0.0294	0.0432	CbGbCtD
Ibuprofen—SLC22A6—Methotrexate—lymphatic system cancer	0.0275	0.0404	CbGbCtD
Ibuprofen—ALB—Methotrexate—lymphatic system cancer	0.0234	0.0344	CbGbCtD
Ibuprofen—ABCB1—Vincristine—lymphatic system cancer	0.0203	0.0297	CbGbCtD
Ibuprofen—ABCB1—Methotrexate—lymphatic system cancer	0.0123	0.018	CbGbCtD
Ibuprofen—PPARG—Etoposide—Teniposide—lymphatic system cancer	0.00568	1	CbGdCrCtD
Ibuprofen—Ecchymosis—Methotrexate—lymphatic system cancer	0.000356	0.00114	CcSEcCtD
Ibuprofen—Bladder pain—Methotrexate—lymphatic system cancer	0.000356	0.00114	CcSEcCtD
Ibuprofen—Neoplasm—Methotrexate—lymphatic system cancer	0.000356	0.00114	CcSEcCtD
Ibuprofen—Mouth ulceration—Methotrexate—lymphatic system cancer	0.000356	0.00114	CcSEcCtD
Ibuprofen—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000354	0.00113	CcSEcCtD
Ibuprofen—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000352	0.00112	CcSEcCtD
Ibuprofen—Alopecia—Mitoxantrone—lymphatic system cancer	0.00035	0.00112	CcSEcCtD
Ibuprofen—Confusional state—Bleomycin—lymphatic system cancer	0.00035	0.00112	CcSEcCtD
Ibuprofen—Vision blurred—Carmustine—lymphatic system cancer	0.00035	0.00112	CcSEcCtD
Ibuprofen—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000349	0.00111	CcSEcCtD
Ibuprofen—Tremor—Carmustine—lymphatic system cancer	0.000348	0.00111	CcSEcCtD
Ibuprofen—Oedema—Bleomycin—lymphatic system cancer	0.000347	0.00111	CcSEcCtD
Ibuprofen—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000347	0.00111	CcSEcCtD
Ibuprofen—Erythema—Mitoxantrone—lymphatic system cancer	0.000345	0.0011	CcSEcCtD
Ibuprofen—Infection—Bleomycin—lymphatic system cancer	0.000345	0.0011	CcSEcCtD
Ibuprofen—Anaemia—Carmustine—lymphatic system cancer	0.000343	0.0011	CcSEcCtD
Ibuprofen—Vomiting—Teniposide—lymphatic system cancer	0.000342	0.00109	CcSEcCtD
Ibuprofen—Sepsis—Methotrexate—lymphatic system cancer	0.000341	0.00109	CcSEcCtD
Ibuprofen—Agitation—Carmustine—lymphatic system cancer	0.000341	0.00109	CcSEcCtD
Ibuprofen—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00034	0.00109	CcSEcCtD
Ibuprofen—Asthenia—Fludarabine—lymphatic system cancer	0.00034	0.00108	CcSEcCtD
Ibuprofen—Rash—Teniposide—lymphatic system cancer	0.00034	0.00108	CcSEcCtD
Ibuprofen—Dermatitis—Teniposide—lymphatic system cancer	0.000339	0.00108	CcSEcCtD
Ibuprofen—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000338	0.00108	CcSEcCtD
Ibuprofen—Headache—Teniposide—lymphatic system cancer	0.000337	0.00108	CcSEcCtD
Ibuprofen—Pruritus—Fludarabine—lymphatic system cancer	0.000335	0.00107	CcSEcCtD
Ibuprofen—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000335	0.00107	CcSEcCtD
Ibuprofen—Leukopenia—Carmustine—lymphatic system cancer	0.000332	0.00106	CcSEcCtD
Ibuprofen—Anorexia—Bleomycin—lymphatic system cancer	0.000331	0.00106	CcSEcCtD
Ibuprofen—Anaemia—Vincristine—lymphatic system cancer	0.000328	0.00105	CcSEcCtD
Ibuprofen—Agitation—Vincristine—lymphatic system cancer	0.000326	0.00104	CcSEcCtD
Ibuprofen—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000325	0.00104	CcSEcCtD
Ibuprofen—Photosensitivity—Methotrexate—lymphatic system cancer	0.000325	0.00104	CcSEcCtD
Ibuprofen—Polyuria—Methotrexate—lymphatic system cancer	0.000325	0.00104	CcSEcCtD
Ibuprofen—Hypotension—Bleomycin—lymphatic system cancer	0.000324	0.00104	CcSEcCtD
Ibuprofen—Diarrhoea—Fludarabine—lymphatic system cancer	0.000324	0.00103	CcSEcCtD
Ibuprofen—Convulsion—Carmustine—lymphatic system cancer	0.000322	0.00103	CcSEcCtD
Ibuprofen—Hypertension—Carmustine—lymphatic system cancer	0.00032	0.00102	CcSEcCtD
Ibuprofen—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00032	0.00102	CcSEcCtD
Ibuprofen—Nausea—Teniposide—lymphatic system cancer	0.00032	0.00102	CcSEcCtD
Ibuprofen—Anaemia—Mitoxantrone—lymphatic system cancer	0.000319	0.00102	CcSEcCtD
Ibuprofen—Vertigo—Vincristine—lymphatic system cancer	0.000318	0.00102	CcSEcCtD
Ibuprofen—Hepatic failure—Methotrexate—lymphatic system cancer	0.000318	0.00101	CcSEcCtD
Ibuprofen—Leukopenia—Vincristine—lymphatic system cancer	0.000317	0.00101	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000316	0.00101	CcSEcCtD
Ibuprofen—Myalgia—Carmustine—lymphatic system cancer	0.000316	0.00101	CcSEcCtD
Ibuprofen—Anxiety—Carmustine—lymphatic system cancer	0.000315	0.00101	CcSEcCtD
Ibuprofen—Paraesthesia—Bleomycin—lymphatic system cancer	0.000312	0.000995	CcSEcCtD
Ibuprofen—Malaise—Mitoxantrone—lymphatic system cancer	0.000311	0.000994	CcSEcCtD
Ibuprofen—Dyspnoea—Bleomycin—lymphatic system cancer	0.000309	0.000988	CcSEcCtD
Ibuprofen—Renal failure acute—Methotrexate—lymphatic system cancer	0.000309	0.000988	CcSEcCtD
Ibuprofen—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000309	0.000987	CcSEcCtD
Ibuprofen—Convulsion—Vincristine—lymphatic system cancer	0.000307	0.00098	CcSEcCtD
Ibuprofen—Hypertension—Vincristine—lymphatic system cancer	0.000306	0.000977	CcSEcCtD
Ibuprofen—Confusional state—Carmustine—lymphatic system cancer	0.000305	0.000976	CcSEcCtD
Ibuprofen—Oedema—Carmustine—lymphatic system cancer	0.000303	0.000968	CcSEcCtD
Ibuprofen—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000303	0.000966	CcSEcCtD
Ibuprofen—Decreased appetite—Bleomycin—lymphatic system cancer	0.000302	0.000964	CcSEcCtD
Ibuprofen—Myalgia—Vincristine—lymphatic system cancer	0.000302	0.000963	CcSEcCtD
Ibuprofen—Visual disturbance—Methotrexate—lymphatic system cancer	0.000301	0.000962	CcSEcCtD
Ibuprofen—Cough—Mitoxantrone—lymphatic system cancer	0.000301	0.000962	CcSEcCtD
Ibuprofen—Infection—Carmustine—lymphatic system cancer	0.000301	0.000961	CcSEcCtD
Ibuprofen—Vomiting—Fludarabine—lymphatic system cancer	0.000301	0.000961	CcSEcCtD
Ibuprofen—Convulsion—Mitoxantrone—lymphatic system cancer	0.000299	0.000955	CcSEcCtD
Ibuprofen—Rash—Fludarabine—lymphatic system cancer	0.000298	0.000953	CcSEcCtD
Ibuprofen—Dermatitis—Fludarabine—lymphatic system cancer	0.000298	0.000952	CcSEcCtD
Ibuprofen—Hypertension—Mitoxantrone—lymphatic system cancer	0.000298	0.000952	CcSEcCtD
Ibuprofen—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000297	0.000947	CcSEcCtD
Ibuprofen—Headache—Fludarabine—lymphatic system cancer	0.000297	0.000947	CcSEcCtD
Ibuprofen—Tachycardia—Carmustine—lymphatic system cancer	0.000296	0.000944	CcSEcCtD
Ibuprofen—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000295	0.000942	CcSEcCtD
Ibuprofen—Myalgia—Mitoxantrone—lymphatic system cancer	0.000294	0.000938	CcSEcCtD
Ibuprofen—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000294	0.000938	CcSEcCtD
Ibuprofen—Anxiety—Mitoxantrone—lymphatic system cancer	0.000293	0.000935	CcSEcCtD
Ibuprofen—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000291	0.00093	CcSEcCtD
Ibuprofen—Discomfort—Mitoxantrone—lymphatic system cancer	0.00029	0.000927	CcSEcCtD
Ibuprofen—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000289	0.000924	CcSEcCtD
Ibuprofen—Oedema—Vincristine—lymphatic system cancer	0.000289	0.000924	CcSEcCtD
Ibuprofen—Anorexia—Carmustine—lymphatic system cancer	0.000289	0.000922	CcSEcCtD
Ibuprofen—Infection—Vincristine—lymphatic system cancer	0.000287	0.000918	CcSEcCtD
Ibuprofen—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000286	0.000913	CcSEcCtD
Ibuprofen—Confusional state—Mitoxantrone—lymphatic system cancer	0.000284	0.000907	CcSEcCtD
Ibuprofen—Nervous system disorder—Vincristine—lymphatic system cancer	0.000284	0.000906	CcSEcCtD
Ibuprofen—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000283	0.000904	CcSEcCtD
Ibuprofen—Hypotension—Carmustine—lymphatic system cancer	0.000283	0.000904	CcSEcCtD
Ibuprofen—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000282	0.000899	CcSEcCtD
Ibuprofen—Oedema—Mitoxantrone—lymphatic system cancer	0.000282	0.000899	CcSEcCtD
Ibuprofen—Nausea—Fludarabine—lymphatic system cancer	0.000281	0.000898	CcSEcCtD
Ibuprofen—Infection—Mitoxantrone—lymphatic system cancer	0.00028	0.000894	CcSEcCtD
Ibuprofen—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00028	0.000893	CcSEcCtD
Ibuprofen—Shock—Mitoxantrone—lymphatic system cancer	0.000277	0.000885	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000276	0.000881	CcSEcCtD
Ibuprofen—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000276	0.000881	CcSEcCtD
Ibuprofen—Urticaria—Bleomycin—lymphatic system cancer	0.000276	0.000881	CcSEcCtD
Ibuprofen—Anorexia—Vincristine—lymphatic system cancer	0.000276	0.00088	CcSEcCtD
Ibuprofen—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000275	0.000878	CcSEcCtD
Ibuprofen—Insomnia—Carmustine—lymphatic system cancer	0.000274	0.000875	CcSEcCtD
Ibuprofen—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000274	0.000874	CcSEcCtD
Ibuprofen—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000272	0.00087	CcSEcCtD
Ibuprofen—Paraesthesia—Carmustine—lymphatic system cancer	0.000272	0.000869	CcSEcCtD
Ibuprofen—Mood swings—Methotrexate—lymphatic system cancer	0.00027	0.000864	CcSEcCtD
Ibuprofen—Hypotension—Vincristine—lymphatic system cancer	0.00027	0.000863	CcSEcCtD
Ibuprofen—Dyspnoea—Carmustine—lymphatic system cancer	0.00027	0.000863	CcSEcCtD
Ibuprofen—Somnolence—Carmustine—lymphatic system cancer	0.000269	0.00086	CcSEcCtD
Ibuprofen—Anorexia—Mitoxantrone—lymphatic system cancer	0.000268	0.000857	CcSEcCtD
Ibuprofen—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000264	0.000842	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000263	0.000841	CcSEcCtD
Ibuprofen—Decreased appetite—Carmustine—lymphatic system cancer	0.000263	0.000841	CcSEcCtD
Ibuprofen—Hypotension—Mitoxantrone—lymphatic system cancer	0.000263	0.00084	CcSEcCtD
Ibuprofen—Insomnia—Vincristine—lymphatic system cancer	0.000262	0.000835	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000262	0.000835	CcSEcCtD
Ibuprofen—Paraesthesia—Vincristine—lymphatic system cancer	0.00026	0.000829	CcSEcCtD
Ibuprofen—Constipation—Carmustine—lymphatic system cancer	0.000259	0.000827	CcSEcCtD
Ibuprofen—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000257	0.000821	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000257	0.000819	CcSEcCtD
Ibuprofen—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000256	0.000817	CcSEcCtD
Ibuprofen—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000253	0.000808	CcSEcCtD
Ibuprofen—Decreased appetite—Vincristine—lymphatic system cancer	0.000251	0.000803	CcSEcCtD
Ibuprofen—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000251	0.000802	CcSEcCtD
Ibuprofen—Somnolence—Mitoxantrone—lymphatic system cancer	0.00025	0.0008	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00025	0.000797	CcSEcCtD
Ibuprofen—Feeling abnormal—Carmustine—lymphatic system cancer	0.00025	0.000797	CcSEcCtD
Ibuprofen—Fatigue—Vincristine—lymphatic system cancer	0.000249	0.000796	CcSEcCtD
Ibuprofen—Asthenia—Bleomycin—lymphatic system cancer	0.000249	0.000795	CcSEcCtD
Ibuprofen—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000248	0.000792	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000248	0.000791	CcSEcCtD
Ibuprofen—Constipation—Vincristine—lymphatic system cancer	0.000247	0.00079	CcSEcCtD
Ibuprofen—Asthma—Methotrexate—lymphatic system cancer	0.000247	0.000788	CcSEcCtD
Ibuprofen—Pruritus—Bleomycin—lymphatic system cancer	0.000246	0.000784	CcSEcCtD
Ibuprofen—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000245	0.000782	CcSEcCtD
Ibuprofen—Eosinophilia—Methotrexate—lymphatic system cancer	0.000244	0.00078	CcSEcCtD
Ibuprofen—Fatigue—Mitoxantrone—lymphatic system cancer	0.000243	0.000775	CcSEcCtD
Ibuprofen—Pancreatitis—Methotrexate—lymphatic system cancer	0.000242	0.000773	CcSEcCtD
Ibuprofen—Constipation—Mitoxantrone—lymphatic system cancer	0.000241	0.000769	CcSEcCtD
Ibuprofen—Abdominal pain—Carmustine—lymphatic system cancer	0.000239	0.000765	CcSEcCtD
Ibuprofen—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000237	0.000755	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000236	0.000755	CcSEcCtD
Ibuprofen—Pancytopenia—Methotrexate—lymphatic system cancer	0.000234	0.000748	CcSEcCtD
Ibuprofen—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000232	0.000741	CcSEcCtD
Ibuprofen—Dysuria—Methotrexate—lymphatic system cancer	0.000231	0.000737	CcSEcCtD
Ibuprofen—Neutropenia—Methotrexate—lymphatic system cancer	0.000231	0.000737	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00023	0.000736	CcSEcCtD
Ibuprofen—Abdominal pain—Vincristine—lymphatic system cancer	0.000229	0.00073	CcSEcCtD
Ibuprofen—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000227	0.000726	CcSEcCtD
Ibuprofen—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000225	0.000719	CcSEcCtD
Ibuprofen—Urticaria—Mitoxantrone—lymphatic system cancer	0.000224	0.000715	CcSEcCtD
Ibuprofen—Hypersensitivity—Carmustine—lymphatic system cancer	0.000223	0.000713	CcSEcCtD
Ibuprofen—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000223	0.000711	CcSEcCtD
Ibuprofen—Pneumonia—Methotrexate—lymphatic system cancer	0.000221	0.000707	CcSEcCtD
Ibuprofen—Vomiting—Bleomycin—lymphatic system cancer	0.000221	0.000705	CcSEcCtD
Ibuprofen—Drowsiness—Methotrexate—lymphatic system cancer	0.00022	0.000703	CcSEcCtD
Ibuprofen—Depression—Methotrexate—lymphatic system cancer	0.000219	0.000701	CcSEcCtD
Ibuprofen—Rash—Bleomycin—lymphatic system cancer	0.000219	0.000699	CcSEcCtD
Ibuprofen—Dermatitis—Bleomycin—lymphatic system cancer	0.000219	0.000698	CcSEcCtD
Ibuprofen—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000218	0.000697	CcSEcCtD
Ibuprofen—Asthenia—Carmustine—lymphatic system cancer	0.000217	0.000694	CcSEcCtD
Ibuprofen—Renal failure—Methotrexate—lymphatic system cancer	0.000216	0.000691	CcSEcCtD
Ibuprofen—Stomatitis—Methotrexate—lymphatic system cancer	0.000214	0.000685	CcSEcCtD
Ibuprofen—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000214	0.000683	CcSEcCtD
Ibuprofen—Hypersensitivity—Vincristine—lymphatic system cancer	0.000213	0.00068	CcSEcCtD
Ibuprofen—Sweating—Methotrexate—lymphatic system cancer	0.000211	0.000674	CcSEcCtD
Ibuprofen—Haematuria—Methotrexate—lymphatic system cancer	0.00021	0.00067	CcSEcCtD
Ibuprofen—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000208	0.000665	CcSEcCtD
Ibuprofen—Epistaxis—Methotrexate—lymphatic system cancer	0.000208	0.000663	CcSEcCtD
Ibuprofen—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000208	0.000663	CcSEcCtD
Ibuprofen—Asthenia—Vincristine—lymphatic system cancer	0.000207	0.000663	CcSEcCtD
Ibuprofen—Diarrhoea—Carmustine—lymphatic system cancer	0.000207	0.000662	CcSEcCtD
Ibuprofen—Nausea—Bleomycin—lymphatic system cancer	0.000206	0.000658	CcSEcCtD
Ibuprofen—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000205	0.000656	CcSEcCtD
Ibuprofen—Asthenia—Mitoxantrone—lymphatic system cancer	0.000202	0.000645	CcSEcCtD
Ibuprofen—Dizziness—Carmustine—lymphatic system cancer	0.0002	0.00064	CcSEcCtD
Ibuprofen—Haemoglobin—Methotrexate—lymphatic system cancer	0.000199	0.000634	CcSEcCtD
Ibuprofen—Diarrhoea—Vincristine—lymphatic system cancer	0.000198	0.000632	CcSEcCtD
Ibuprofen—Haemorrhage—Methotrexate—lymphatic system cancer	0.000198	0.000631	CcSEcCtD
Ibuprofen—Hepatitis—Methotrexate—lymphatic system cancer	0.000198	0.000631	CcSEcCtD
Ibuprofen—Pharyngitis—Methotrexate—lymphatic system cancer	0.000196	0.000626	CcSEcCtD
Ibuprofen—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000195	0.000623	CcSEcCtD
Ibuprofen—Urethral disorder—Methotrexate—lymphatic system cancer	0.000194	0.000618	CcSEcCtD
Ibuprofen—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000193	0.000615	CcSEcCtD
Ibuprofen—Vomiting—Carmustine—lymphatic system cancer	0.000193	0.000615	CcSEcCtD
Ibuprofen—Dizziness—Vincristine—lymphatic system cancer	0.000191	0.000611	CcSEcCtD
Ibuprofen—Rash—Carmustine—lymphatic system cancer	0.000191	0.00061	CcSEcCtD
Ibuprofen—Dermatitis—Carmustine—lymphatic system cancer	0.000191	0.000609	CcSEcCtD
Ibuprofen—Visual impairment—Methotrexate—lymphatic system cancer	0.00019	0.000608	CcSEcCtD
Ibuprofen—Headache—Carmustine—lymphatic system cancer	0.00019	0.000606	CcSEcCtD
Ibuprofen—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000187	0.000596	CcSEcCtD
Ibuprofen—Tinnitus—Methotrexate—lymphatic system cancer	0.000184	0.000588	CcSEcCtD
Ibuprofen—Vomiting—Vincristine—lymphatic system cancer	0.000184	0.000587	CcSEcCtD
Ibuprofen—Rash—Vincristine—lymphatic system cancer	0.000182	0.000582	CcSEcCtD
Ibuprofen—Dermatitis—Vincristine—lymphatic system cancer	0.000182	0.000582	CcSEcCtD
Ibuprofen—Headache—Vincristine—lymphatic system cancer	0.000181	0.000579	CcSEcCtD
Ibuprofen—Nausea—Carmustine—lymphatic system cancer	0.00018	0.000575	CcSEcCtD
Ibuprofen—Vomiting—Mitoxantrone—lymphatic system cancer	0.000179	0.000572	CcSEcCtD
Ibuprofen—Immune system disorder—Methotrexate—lymphatic system cancer	0.000178	0.00057	CcSEcCtD
Ibuprofen—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000178	0.000568	CcSEcCtD
Ibuprofen—Rash—Mitoxantrone—lymphatic system cancer	0.000178	0.000567	CcSEcCtD
Ibuprofen—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000177	0.000567	CcSEcCtD
Ibuprofen—Chills—Methotrexate—lymphatic system cancer	0.000177	0.000566	CcSEcCtD
Ibuprofen—Headache—Mitoxantrone—lymphatic system cancer	0.000176	0.000563	CcSEcCtD
Ibuprofen—Alopecia—Methotrexate—lymphatic system cancer	0.000175	0.000557	CcSEcCtD
Ibuprofen—Mental disorder—Methotrexate—lymphatic system cancer	0.000173	0.000553	CcSEcCtD
Ibuprofen—Malnutrition—Methotrexate—lymphatic system cancer	0.000172	0.000549	CcSEcCtD
Ibuprofen—Erythema—Methotrexate—lymphatic system cancer	0.000172	0.000549	CcSEcCtD
Ibuprofen—Nausea—Vincristine—lymphatic system cancer	0.000172	0.000549	CcSEcCtD
Ibuprofen—Dysgeusia—Methotrexate—lymphatic system cancer	0.000168	0.000538	CcSEcCtD
Ibuprofen—Nausea—Mitoxantrone—lymphatic system cancer	0.000167	0.000534	CcSEcCtD
Ibuprofen—Vision blurred—Methotrexate—lymphatic system cancer	0.000162	0.000517	CcSEcCtD
Ibuprofen—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00016	0.000509	CcSEcCtD
Ibuprofen—Anaemia—Methotrexate—lymphatic system cancer	0.000159	0.000508	CcSEcCtD
Ibuprofen—Malaise—Methotrexate—lymphatic system cancer	0.000155	0.000495	CcSEcCtD
Ibuprofen—Vertigo—Methotrexate—lymphatic system cancer	0.000154	0.000493	CcSEcCtD
Ibuprofen—Leukopenia—Methotrexate—lymphatic system cancer	0.000154	0.000492	CcSEcCtD
Ibuprofen—Cough—Methotrexate—lymphatic system cancer	0.00015	0.000479	CcSEcCtD
Ibuprofen—Convulsion—Methotrexate—lymphatic system cancer	0.000149	0.000476	CcSEcCtD
Ibuprofen—Myalgia—Methotrexate—lymphatic system cancer	0.000146	0.000467	CcSEcCtD
Ibuprofen—Arthralgia—Methotrexate—lymphatic system cancer	0.000146	0.000467	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000145	0.000464	CcSEcCtD
Ibuprofen—Discomfort—Methotrexate—lymphatic system cancer	0.000145	0.000462	CcSEcCtD
Ibuprofen—Confusional state—Methotrexate—lymphatic system cancer	0.000141	0.000452	CcSEcCtD
Ibuprofen—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00014	0.000448	CcSEcCtD
Ibuprofen—Infection—Methotrexate—lymphatic system cancer	0.000139	0.000445	CcSEcCtD
Ibuprofen—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000138	0.000439	CcSEcCtD
Ibuprofen—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000137	0.000439	CcSEcCtD
Ibuprofen—Skin disorder—Methotrexate—lymphatic system cancer	0.000136	0.000435	CcSEcCtD
Ibuprofen—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000136	0.000433	CcSEcCtD
Ibuprofen—Anorexia—Methotrexate—lymphatic system cancer	0.000134	0.000427	CcSEcCtD
Ibuprofen—Hypotension—Methotrexate—lymphatic system cancer	0.000131	0.000419	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000128	0.000408	CcSEcCtD
Ibuprofen—Insomnia—Methotrexate—lymphatic system cancer	0.000127	0.000405	CcSEcCtD
Ibuprofen—Paraesthesia—Methotrexate—lymphatic system cancer	0.000126	0.000402	CcSEcCtD
Ibuprofen—Dyspnoea—Methotrexate—lymphatic system cancer	0.000125	0.0004	CcSEcCtD
Ibuprofen—Somnolence—Methotrexate—lymphatic system cancer	0.000125	0.000398	CcSEcCtD
Ibuprofen—Dyspepsia—Methotrexate—lymphatic system cancer	0.000124	0.000394	CcSEcCtD
Ibuprofen—Decreased appetite—Methotrexate—lymphatic system cancer	0.000122	0.00039	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000121	0.000387	CcSEcCtD
Ibuprofen—Fatigue—Methotrexate—lymphatic system cancer	0.000121	0.000386	CcSEcCtD
Ibuprofen—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000116	0.000369	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000115	0.000366	CcSEcCtD
Ibuprofen—Urticaria—Methotrexate—lymphatic system cancer	0.000111	0.000356	CcSEcCtD
Ibuprofen—Abdominal pain—Methotrexate—lymphatic system cancer	0.000111	0.000354	CcSEcCtD
Ibuprofen—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000103	0.00033	CcSEcCtD
Ibuprofen—Asthenia—Methotrexate—lymphatic system cancer	0.000101	0.000322	CcSEcCtD
Ibuprofen—Pruritus—Methotrexate—lymphatic system cancer	9.93e-05	0.000317	CcSEcCtD
Ibuprofen—Diarrhoea—Methotrexate—lymphatic system cancer	9.6e-05	0.000307	CcSEcCtD
Ibuprofen—Dizziness—Methotrexate—lymphatic system cancer	9.28e-05	0.000296	CcSEcCtD
Ibuprofen—Vomiting—Methotrexate—lymphatic system cancer	8.92e-05	0.000285	CcSEcCtD
Ibuprofen—Rash—Methotrexate—lymphatic system cancer	8.85e-05	0.000283	CcSEcCtD
Ibuprofen—Dermatitis—Methotrexate—lymphatic system cancer	8.84e-05	0.000282	CcSEcCtD
Ibuprofen—Headache—Methotrexate—lymphatic system cancer	8.79e-05	0.000281	CcSEcCtD
Ibuprofen—Nausea—Methotrexate—lymphatic system cancer	8.34e-05	0.000266	CcSEcCtD
